Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03700359
What this trial is testing

Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03896503
What this trial is testing

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaExtrapulmonary Small Cell Neuroendocrine CarcinomaLimited Stage Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 104
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00057837
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Eastern Cooperative Oncology Group 140
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07699237
What this trial is testing

Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)

Who this might be right for
Extensive Disease Small Cell Lung Cancer
University of Cologne 54
Large-scale testing (Phase 3)UnknownNCT02875457
What this trial is testing

Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 100
Early research (Phase 1)Active Not RecruitingNCT03923270
What this trial is testing

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall-cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 25
Not applicableActive Not RecruitingNCT06008353
What this trial is testing

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

Who this might be right for
Extensive-stage Small-cell Lung Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03672773
What this trial is testing

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Recurrent Extensive Stage Small Cell Lung CarcinomaRefractory Extensive Stage Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer Center 35
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT05924841
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06502977
What this trial is testing

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 32
Testing effectiveness (Phase 2)Ended earlyNCT03026166
What this trial is testing

Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648200
What this trial is testing

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China 100
Not applicableStudy completedNCT00899028
What this trial is testing

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Who this might be right for
Lung Cancer
Vanderbilt University Medical Center 689
Large-scale testing (Phase 3)Study completedNCT00061919
What this trial is testing

Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University College, London 724
Testing effectiveness (Phase 2)Study completedNCT00284154
What this trial is testing

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small CellLung Cancer
SCRI Development Innovations, LLC 51
Next Page